GIA
BMY icon

GHP Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

GHP Investment Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$343K Sell
5,952
-400
-6% -$23K 0.01% 360
2026
Q1 		$385K Sell
6,352
-1,122
-15% -$65.4K 0.02% 334
2025
Q4 		$403K Sell
7,474
-8
-0.1% -$385 0.02% 326
2025
Q3 		$337K Hold
7,482
– – 0.01% 337
2025
Q2 		$346K Buy
7,482
+1,149
+18% +$56.4K 0.02% 328
2025
Q1 		$386K Hold
6,333
– – 0.02% 318
2024
Q4 		$358K Hold
6,333
– – 0.02% 325
2024
Q3 		$328K Buy
6,333
+353
+6% +$16.6K 0.02% 330
2024
Q2 		$248K Hold
5,980
– – 0.01% 351
2024
Q1 		$324K Hold
5,980
– – 0.02% 336
2023
Q4 		$307K Sell
5,980
-96
-2% -$5.04K 0.02% 339
2023
Q3 		$343K Buy
6,076
+386
+7% +$23.7K 0.02% 324
2023
Q2 		$348K Sell
5,690
-36
-0.6% -$2.41K 0.02% 332
2023
Q1 		$397K Buy
5,726
+27
+0.5% +$1.9K 0.03% 316
2022
Q4 		$410K Buy
5,699
+86
+2% +$6.49K 0.03% 313
2022
Q3 		$399K Hold
5,613
– – 0.03% 302
2022
Q2 		$432K Sell
5,613
-113
-2% -$8.61K 0.03% 297
2022
Q1 		$418K Buy
5,726
+180
+3% +$12.1K 0.03% 299
2021
Q4 		$346K Sell
5,546
-1,227
-18% -$72K 0.02% 273
2021
Q3 		$401K Hold
6,773
– – 0.03% 247
2021
Q2 		$453K Sell
6,773
-126
-2% -$8.22K 0.04% 236
2021
Q1 		$436K Sell
6,899
-187
-3% -$11.6K 0.04% 237
2020
Q4 		$440K Buy
7,086
+315
+5% +$19.4K 0.04% 229
2020
Q3 		$408K Buy
6,771
+55
+0.8% +$3.31K 0.05% 230
2020
Q2 		$395K Sell
6,716
-3,965
-37% -$237K 0.05% 233
2020
Q1 		$595K Buy
10,681
+461
+5% +$28.2K 0.09% 203
2019
Q4 		$656K Buy
10,220
+5,460
+115% +$313K 0.07% 217
2019
Q3 		$241K Sell
4,760
-25
-0.5% -$1.18K 0.03% 280
2019
Q2 		$217K Buy
4,785
+25
+0.5% +$1.16K 0.03% 296
2019
Q1 		$227K Hold
4,760
– – 0.03% 291
2018
Q4 		$247K Sell
4,760
-50
-1% -$2.69K 0.04% 265
2018
Q3 		$299K Hold
4,810
– – 0.04% 261
2018
Q2 		$266K Sell
4,810
-50
-1% -$2.7K 0.04% 262
2018
Q1 		$307K Sell
4,860
-467
-9% -$30K 0.04% 254
2017
Q4 		$326K Sell
5,327
-236
-4% -$14.8K 0.05% 258
2017
Q3 		$355K Buy
5,563
+105
+2% +$6.13K 0.05% 249
2017
Q2 		$304K Sell
5,458
-2,620
-32% -$143K 0.05% 262
2017
Q1 		$439K Buy
8,078
+69
+0.9% +$3.79K 0.08% 232
2016
Q4 		$468K Buy
8,009
+2,293
+40% +$125K 0.09% 223
2016
Q3 		$308K Buy
5,716
+2
+0% +$128 0.06% 245
2016
Q2 		$420K Buy
5,714
+1
+0% +$71 0.09% 221
2016
Q1 		$365K Buy
5,713
+1
+0% +$63 0.08% 225
2015
Q4 		$393K Buy
5,712
+1
+0% +$66 0.09% 217
2015
Q3 		$338K Buy
5,711
+2
+0% +$127 0.09% 218
2015
Q2 		$377K Buy
5,709
+1
+0% +$66 0.09% 210
2015
Q1 		$368K Buy
5,708
+1
+0% +$63 0.1% 207
2014
Q4 		$337K Buy
5,707
+1
+0% +$56 0.09% 205
2014
Q3 		$292K Buy
5,706
+2
+0% +$100 0.09% 214
2014
Q2 		$277K Buy
5,704
+2
+0% +$99 0.08% 219
2014
Q1 		$296K Buy
5,702
+1
+0% +$53 0.09% 208
2013
Q4 		$303K Buy
5,701
+2
+0% +$102 0.1% 207
2013
Q3 		$264K Buy
5,699
+1
+0% +$44 0.1% 217
2013
Q2 		$255K Buy
+5,698
New +$247K 0.1% 210

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

GHP Investment Advisors's BMY Position: Q2 2026 in Review

GHP Investment Advisors reduced its Bristol-Myers Squibb (BMY) stake by 6.3% in Q2 2026, selling an estimated $23K and leaving 5,952 shares worth $343K. The position accounts for 0.01% of the portfolio, ranked #360.

GHP Investment Advisors first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $656K in Q4 2019. 889 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • GHP Investment Advisors held 5,952 shares of Bristol-Myers Squibb worth $343K as of Q2 2026.
  • GHP Investment Advisors sold 400 Bristol-Myers Squibb shares in Q2 2026, an estimated $23K.
  • Bristol-Myers Squibb made up 0.01% of GHP Investment Advisors's portfolio in Q2 2026, its #360 holding.
  • GHP Investment Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • GHP Investment Advisors's Bristol-Myers Squibb position peaked at $656K in Q4 2019.
  • 889 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.